{"schema_version":"secwatch.filing_event.v1","accession":"0001367644-25-000114","form_type":"8-K","ticker":"EBS","cik":"0001367644","company_name":"Emergent BioSolutions Inc.","filed_at":"2025-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.076301+00:00","generated_at":"2026-05-22T11:18:43.737231+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Emergent BioSolutions stockholders elect three Class I directors, ratify auditor, approve advisory compensation","bullets":["Annual meeting held April 30, 2025; 36,140,808 shares (67% of outstanding) present.","Class I directors Keith Katkin, Ronald Richard, Kathryn Zoon each elected with >18M votes for.","Ernst & Young ratified as independent auditor for FY2025 with 34,773,959 for, 1,152,704 against.","Advisory vote on named executive officer compensation approved with 18,928,777 for, 3,537,501 against."],"urls":{"canonical":"https://secwatch.observer/filing/0001367644-25-000114","json":"https://secwatch.observer/filing/0001367644-25-000114.json","markdown":"https://secwatch.observer/filing/0001367644-25-000114.md","text":"https://secwatch.observer/filing/0001367644-25-000114.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000114/0001367644-25-000114-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000114/ebs-20250430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T11:18:43.737231+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}